Ophthalmology News

• Cluster of Eye Syphilis Cases Prompts CDC Concern A rare presentation of syphilis has experts questioning whether the bacterium has mutated.
  Medscape Medical News, December 18, 2023
• Infections Down in Acute Care Hospitals Prevention strategies to reduce healthcare-associated infections are having an effect, according to a new report on national- and state-level incidence.
  Medscape Medical News, December 18, 2023
• Debate Grows Over Facility Fees, Lawmakers Urge Transparency There's continued interest in more transparency about medical costs, in particular facility fees. But there's also a divided opinion about eliminating these payments for US medical care.
  Medscape Medical News, December 18, 2023
• Alert FDA Approves Implant for Glaucoma An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.
  Medscape Medical News, December 15, 2023
• Top 10 Fictional Docs on Streaming TV Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
  Medscape News Slideshows, December 15, 2023
• Report: Kidney Disease Evident in These Eye Issues An analysis of four new studies found that retinal and choroidal thickness in the back of the eye correlates with kidney function in patients with chronic kidney disease.
  Medscape Medical News, December 11, 2023
• How’s the Food? Rate Your Hospital Cafeteria Historically, hospital cafeterias have not been celebrated for the quality of their cuisine, typically feeding their staff from the same kitchen that prepared patient meals. How would you rate your hospital's cafeteria?
  Medscape Reader Polls, December 05, 2023
• Cyberattacks Challenge Canadian Health Information Systems A new analysis recommends a four-stage plan for physicians and health systems to improve their cybersecurity practices.
  Medscape Medical News, November 27, 2023
• Lebrikizumab Gets the Nod in the EU for Atopic Dermatitis Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.
  MDedge News, November 20, 2023
• Before Signing an Offer Letter: Read This You just received an offer letter, but should you sign it right away? How legally binding is it? Is it the same as a contract? Experts weigh in.
  Medscape Medical News, November 17, 2023
• AAO 2023 Oral Therapy Shown to Preserve Retina in Stargardt Disease A once-daily pill of modified vitamin A slowed the rate of retinal degeneration in patients with Stargardt disease, a rare genetic eye disease that can cause vision loss.
  Medscape Medical News, November 17, 2023
• WHO: Smoking Cessation Reduces Risk of Type 2 Diabetes Up to 40% A policy brief details the risks of smoking in type 2 diabetes — along with the benefits of cessation; health professionals urged to help patients quit.
  Medscape Medical News, November 17, 2023
• Amazon Says Unapproved Eye Drops Being Removed From Website Amazon said on Wednesday it was in the process of removing seven unapproved eye drops from its e-commerce platform following a warning letter from the U.S. health regulator earlier this week.
  Reuters Health Information, November 15, 2023
• AAO 2023 Pediatric PKP Graft Failure More Likely at Younger Ages Performing other eye procedures during corneal transplantation in children may increase the odds of a poor outcome, according to research presented at the American Academy of Ophthalmology 2023 annual meeting.
  Medscape Medical News, November 16, 2023
• FDA Warns Amazon Against Sale of Unapproved Eye Drops The US Food and Drug Administration said on Tuesday it had sent a warning letter to Amazon.com related to sale of seven unapproved eye drops on the company's e-commerce platform.
  Reuters Health Information, November 14, 2023
• AAO 2023 At 2 Years, Anti-VEGF Treatment, Laser Equal for ROP: Study For treatment of retinopathy of prematurity, intravitreal aflibercept (Eylea) and laser photocoagulation showed equivocal results at age 2 years, a European-based clinical trial found.
  Medscape Medical News, November 15, 2023
• Surveillance Imaging After Head, Neck Cancer Remission? With no apparent benefit for most, investigators say routine surveillance imaging in asymptomatic patients with head and neck cancer "should be discouraged."
  Medscape Medical News, November 15, 2023
• Study Confirms Small Blood Cancer Risk From CT Scans The increased risk of hematological malignancies from CT radiation exposure in children and young adults should be viewed in the context of the substantial benefit these scans offer, experts say.
  Medscape Medical News, November 15, 2023
• AAO 2023 GLP-1s Don't Appear to Worsen Diabetic Retinopathy Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don't experience a worsening of the condition, a new study found, but they still require screening and follow-up.
  Medscape Medical News, November 14, 2023
• AAO 2023 Novel Approach to Dry Eye Shows Promise The experimental drug tavilermide appeared to be effective in patients with the worst symptoms of the condition, a new study finds.
  Medscape Medical News, November 13, 2023
• Should Physicians Go to Work When Sick? Although most doctors believe it's best to stay home if they're ill, today's healthcare system makes the answer much more complicated.
  Medscape Medical News, November 13, 2023
• Short Steroid Taper Tested With Tocilizumab for GCA Results from a pilot study examining a shortened prednisone taper of 8 weeks' length rather than 26 weeks suggest it may be possible to reduce patients' duration of exposure to glucocorticoids.
  Medscape Medical News, November 10, 2023
• FTC Considers Proposals on Mergers and Noncompete Clauses AMA and ACEP support proposed changes that would affect workforce hiring and working conditions for physicians.
  Medscape Medical News, November 10, 2023
• Surgeons in New York Announce World's First Eye Transplant Surgeons in New York have performed the first-ever whole-eye transplant in a human, they announced on Thursday, an accomplishment being hailed as a breakthrough even though the patient has not regained sight in the eye.
  Reuters Health Information, November 09, 2023
• Senator Expresses 'Disappointment' in FTC's Amgen Decision Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the US Federal Trade Commission's decision to allow pharmaceutical firm Amgen to move forward with its acquisition of Horizon Therapeutics.
  Reuters Health Information, November 09, 2023
• AAO 2023 Study Shows Tarcocimab May Improve Diabetic Retinopathy A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy.
  Medscape Medical News, November 09, 2023
• 20 Best Holiday Gift Ideas for Doctors 2023 Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
  Medscape News Slideshows, November 09, 2023
• Even an Hour's Walk a Week Lowers Risk in Type 2 Diabetes Leisure time activity equivalent to less than 1.5 hours' walking time per week may be enough to substantially reduce the risk for neuropathy and nephropathy in type 2 diabetes, say Danish researchers.
  Medscape Medical News, August 29, 2023
• Could Retinal Changes Be a Harbinger of Parkinson's? Changes in retinal tissues known to be associated with Parkinson's disease may occur up to 7 years before clinical symptoms of the disease appear.
  Medscape Medical News, August 24, 2023
• As MOC Debate Heats Up, Cardiology Societies Weigh In The MOC process is once again under attack by cardiologists and other specialty physicians. A petition aiming to end the requirements has garnered more than 17,000 and counting signatures.
  Medscape Medical News, August 22, 2023
• Primary Care Vision Testing Rates in Children Low Vision testing rates by primary care physicians in children were low and differed by insurance status, an anlysis of pooled data found.
  MDedge News, August 17, 2023
• Biosimilars Comparable to Aflibercept in Macular Disease Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity.
  Medscape Medical News, August 03, 2023